Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Medical Center Pharmacy is recalling 250 mL bags of Gentamicin/Bacitracin Bladder Irrigation due to concerns that production processes cannot assure sterility.
Medical Center Pharmacy is recalling Vancomycin Opthal 14 mg drops because production processes could not assure sterility. The product was distributed to patients in Tennessee.
Dr. Reddy's is recalling Phytonadione Injectable Emulsion ampules because they may break or shatter when opened.
Medical Center Pharmacy is recalling two bottles of Mitomycin 0.04% Ophth DR eye drops because production processes could not assure sterility.
Par Pharmaceutical is recalling 29,352 bottles of Glycopyrrolate Tablets, USP 1 mg, because an unknown impurity was detected.
Medical Center Pharmacy is recalling Morphine 2 mg/mL CADD Cassettes because production processes cannot assure sterility. Patients in Tennessee who received specific prescriptions should contact their healthcare provider.
Lupin Pharmaceuticals is recalling 25,944 bottles of Lisinopril 30 mg tablets because a 5 mg tablet was found mixed into a 30 mg bottle.
Akorn Inc. is recalling Fentanyl Citrate Injection, USP, 100 mcg/2 mL, because retained sample testing showed total impurities exceeded the allowed limit.
Thrive Pharmacy is recalling 89 Buprenorphine Black Cherry 2 mg troches in Florida because the medication was found to be subpotent.
Thrive Pharmacy is voluntarily recalling 71 Buprenorphine troches in Florida because the medication was found to be subpotent.
Thrive Pharmacy is recalling 403 buprenorphine troches in Florida because they contain less active ingredient than labeled.
Glaxosmithkline is recalling specific lots of Advil Liqui-Gel Mini because the Drug Facts Panel lacks required safety warning information.
Pharmaceutical Associates, Inc. is recalling Nystatin Oral Suspension because it tested below the required potency level.
Glaxosmithkline is recalling specific lots of Advil Allergy and Congestion Relief tablets because they lack required safety warning information in the Drug Facts Panel.
GlaxoSmithKline is recalling specific lots of Advil Allergy and Congestion Relief because the Drug Facts Panel lacks required safety warning information.
Glaxosmithkline is recalling 446,628 bottles of Advil Liqui-Gel Minis because certain lots lack required safety warning information in the Drug Facts Panel.
Glaxosmithkline is recalling specific lots of Infants Advil (Ibuprofen) because the Drug Facts Panel lacks required safety warning information.
Nostrum Laboratories is recalling Theophylline Extended-Release Tablets because poor manufacturing practices resulted in incorrect lot and expiration date labeling.
Jubilant Draximage is recalling DRAXIMAGE DTPA kits because they failed stability specifications. The affected product was distributed throughout the United States.
Mylan Pharmaceuticals is recalling specific lots of 5mg Tacrolimus capsules because 1mg capsules may be present in the bottles.
Grato Holdings, Inc. is recalling 659 bottles of Colostat homeopathic remedy because the indications on the product label are incorrect.
Med Man Distribution is recalling UP2 dietary supplements because FDA analysis found undeclared sildenafil, a prescription drug, in the product.
Perrigo Company PLC is recalling specific lots of Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, due to a CGMP deviation and possible contamination with the impurity N-nitrosodimethylamine.
Perrigo Company PLC is recalling specific lots of Regular Strength Acid Reducer Ranitidine tablets due to a CGMP deviation and possible contamination with the impurity N-nitrosodimethylamine.
Perrigo is recalling Maximum Strength Acid Reducer Ranitidine tablets due to a CGMP deviation and possible contamination with the impurity N-nitrosodimethylamine.